Amid the resurgence of the COVID-19 pandemic, The food and drug authorities in Korea have been taking steps to approve COVID-19 treatments.

According to the Ministry of Food and Drug Safety (MFDS) on the 19th, the agency began reviewing Ildong Pharmaceutical's ‘Xocova’ and MSD Korea’s ‘Lagevrio,' which the companies have submitted applications for approval in Korea.

“Currently, three drugs are licensed or approved for emergency use in Korea - the oral drugs 'Paxlovid' and ‘Lagevrio’ and the injectable drug ‘Veklury.’” said an MFDS official, ”and we are reviewing the applications of additional products that have applied for marketing authorization thereafter.”